HPV is not included in standard STD tests. When you go to a clinic and ask for a “full STD panel,” you’ll typically be screened for chlamydia, gonorrhea, syphilis, and HIV. Depending on your risk factors, hepatitis B and herpes may be added. But HPV is left out entirely, and there are specific reasons for that.
What a Standard STD Panel Actually Covers
A routine STD screening generally tests for four to six infections, depending on your age, sex, and sexual history. For sexually active women under 25, yearly chlamydia and gonorrhea testing is recommended. Men who have sex with men are advised to test at least once a year for syphilis, chlamydia, gonorrhea, and HIV. Pregnant women are usually screened for HIV, hepatitis B, chlamydia, and syphilis.
None of these standard panels include HPV. Even if you specifically ask your provider for “everything,” HPV won’t be part of the package unless you request it separately, and even then, testing is only available in certain situations.
Why HPV Is Left Out
The main reason HPV isn’t part of routine STD screening is that the infection is extraordinarily common and usually harmless. Genital HPV prevalence in men peaks around 35% in the 25 to 29 age group. Most sexually active people will contract at least one type of HPV during their lifetime. In the vast majority of cases, the immune system clears the virus on its own within a year or two without causing any symptoms or health problems.
Testing everyone for an infection that’s this widespread and that resolves on its own would generate enormous numbers of positive results that don’t require treatment. A positive HPV result in a 22-year-old, for example, would likely cause significant anxiety over an infection that will almost certainly clear without intervention. There’s no treatment for the virus itself, only for the problems it can cause, like abnormal cervical cells or genital warts. So screening healthy, low-risk people for HPV creates worry without offering a clear next step.
When HPV Testing Is Available
HPV testing does exist, but it’s used in a narrow context: cervical cancer screening for women. The FDA has approved HPV testing specifically for women over 30. It works alongside or in place of the Pap smear, which looks for abnormal cells on the cervix that could become cancerous over time.
The CDC’s current cervical cancer screening guidelines break down by age:
- Ages 21 to 29: Pap tests every three years. HPV testing is not routinely recommended in this age group because HPV infections are so common in younger women and almost always resolve.
- Ages 30 to 65: Three options are available. An HPV test alone (called primary HPV testing) every five years, an HPV test combined with a Pap test every five years, or a Pap test alone every three years.
- Over 65: Screening can stop if recent results have been normal and there’s no history of cervical precancer.
The HPV test used in cervical screening is highly accurate. It catches about 94.6% of significant cervical abnormalities, compared to 55.4% for the Pap smear alone. That’s why HPV testing has become the preferred primary screening method for women 30 and older.
There’s No Approved HPV Test for Men
No FDA-approved HPV test exists for men. There’s no reliable, validated way to screen men for HPV through blood, urine, or swab testing in a clinical setting. When men develop genital warts, the diagnosis is made by visual inspection. About 90% of genital warts are caused by HPV types 6 and 11, which are low-risk strains that don’t cause cancer. A biopsy can confirm the diagnosis if warts look unusual, but HPV DNA testing is not recommended for diagnosing warts because the results don’t change how they’re treated.
For HPV-related cancers in men (affecting the throat, anus, or penis), there are no routine screening programs. Anal Pap smears are sometimes used for men at higher risk, particularly men living with HIV, but this isn’t standardized the way cervical screening is.
How to Get Tested If You Want It
If you’re a woman 30 or older, you can ask your provider to include an HPV test as part of your cervical cancer screening. In many cases, it’s already part of the protocol. If you’re under 30, your provider may not offer it unless you have an abnormal Pap result, since a positive HPV test at that age is expected and rarely actionable.
At-home HPV test kits are also available, typically costing $50 to $75 without insurance. Clinic-based testing ranges from about $30 to over $200. These self-collection kits involve a vaginal swab you mail to a lab, and they screen for high-risk HPV types linked to cervical cancer. They are not available for men.
If you’re concerned about HPV because you’ve noticed warts or other symptoms, bring that up directly with your provider. Genital warts are diagnosed visually, and your clinician can discuss treatment options for removing them. For concerns about HPV-related cancers, your provider can assess your individual risk and recommend appropriate follow-up based on your symptoms and history.
Vaccination Covers the Most Dangerous Strains
The current HPV vaccine (Gardasil-9) protects against nine HPV types: 6, 11, 16, 18, 31, 33, 45, 52, and 58. Types 16 and 18 are responsible for the majority of HPV-related cancers, while types 6 and 11 cause most genital warts. The vaccine is approved for people ages 9 through 45 and has already led to measurable drops in genital wart rates among teens and young adults.
Because there’s no reliable way to screen for HPV across the board, vaccination is the primary prevention strategy. It’s most effective when given before someone is exposed to the virus, which is why it’s routinely recommended starting at age 11 or 12. But even if you’re older and weren’t vaccinated as a teen, the vaccine can still offer protection against strains you haven’t yet encountered.